Multimodal analgesia – the standard of care
Multimodal analgesia is now the standard of care for post-operative pain relief and it can readily be explained to patients, says Dr Alexander Tzabazis, Deputy Director of Anaesthesiology… read more.
Multimodal analgesia is now the standard of care for post-operative pain relief and it can readily be explained to patients, says Dr Alexander Tzabazis, Deputy Director of Anaesthesiology… read more.
There is now extensive evidence to support the multimodal approach to peri-operative pain relief and the role of intravenous paracetamol and ibuprofen, according to Dr Alexander Tzabazis, Deputy… read more.
Enhanced recovery after surgery (ERAS) offers many advantages including early functional recovery and reduced exposure to opioids. IMI spoke to Dr Alexander Tzabazis, Deputy Director of Anaesthesiology and… read more.
With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at… read more.
A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the… read more.
Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK… read more.
Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN describes how some critical factors need to be taken into account when planning and organising PCN pharmacy… read more.
Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN explains the positive findings from a randomised controlled trial that evaluated the impact of a medicines’ optimisation… read more.
The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary… read more.
The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist… read more.
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.
A global call to action issued by the International Pharmaceutical Federation (FIP) on 13th December 2021 sets out 18 urgent actions needed from academic institutions, professional organisations, policymakers… read more.